Gaviscon
RxNorm concept 25655, brand name (bn).
- RxCUI
- 25655
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/25655 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Gaviscon] (SBD, ingredient of)
- aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon] (SBDF, ingredient of)
- aluminum hydroxide / magnesium carbonate Chewable Tablet [Gaviscon] (SBDF, ingredient of)
- aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon] (SBD, ingredient of)
- aluminum hydroxide 160 MG / magnesium carbonate 105 MG [Gaviscon] (SBDC, ingredient of)
- aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML [Gaviscon] (SBDC, ingredient of)
- Gaviscon Pill (SBDG, ingredient of)
- Gaviscon Oral Liquid Product (SBDG, ingredient of)
- Gaviscon Oral Product (SBDG, ingredient of)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon] (SBDC, ingredient of)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon] (SBD, ingredient of)
- Gaviscon Chewable Product (SBDG, ingredient of)
- aluminum hydroxide (IN, tradename of)
- magnesium carbonate (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 25655 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/25655 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 25655. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.